Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms

Background Genome-wide expression profiling is increasingly being used to identify transcriptional changes induced by drugs and environmental stressors. In this context, the Toxicogenomics Project–Genomics Assisted Toxicity Evaluation system (TG-GATEs) project generated transcriptional profiles from rat liver samples and human/rat cultured primary hepatocytes exposed to more than 100 different chemicals. Objectives To assess the capacity of the cell culture models to recapitulate pathways induced by chemicals in vivo, we leveraged the TG-GATEs data set to compare the early transcriptional responses observed in the liver of rats treated with a large set of chemicals with those of cultured rat and human primary hepatocytes challenged with the same compounds in vitro. Methods We developed a new pathway-based computational pipeline that efficiently combines gene set enrichment analysis (GSEA) using pathways from the Reactome database with biclustering to identify common modules of pathways that are modulated by several chemicals in vivo and in vitro across species. Results We found that some chemicals induced conserved patterns of early transcriptional responses in in vitro and in vivo settings, and across human and rat genomes. These responses involved pathways of cell survival, inflammation, xenobiotic metabolism, oxidative stress, and apoptosis. Moreover, our results support the transforming growth factor beta receptor (TGF-βR) signaling pathway as a candidate biomarker associated with exposure to environmental toxicants in primary human hepatocytes. Conclusions Our integrative analysis of toxicogenomics data provides a comprehensive overview of biochemical perturbations affected by a large panel of chemicals. Furthermore, we show that the early toxicological response occurring in animals is recapitulated in human and rat primary hepatocyte cultures at the molecular level, indicating that these models reproduce key pathways in response to chemical stress. These findings expand our understanding and interpretation of toxicogenomics data from human hepatocytes exposed to environmental toxicants. Citation El-Hachem N, Grossmann P, Blanchet-Cohen A, Bateman AR, Bouchard N, Archambault J, Aerts HJ, Haibe-Kains B. 2016. Characterization of conserved toxicogenomic responses in chemically exposed hepatocytes across species and platforms. Environ Health Perspect 124:313–320; http://dx.doi.org/10.1289/ehp.1409157

[1]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[2]  G. Gores,et al.  Drug‐induced liver injury: Mechanisms and test systems , 2001, Hepatology.

[3]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[4]  Sven Bergmann,et al.  Iterative signature algorithm for the analysis of large-scale gene expression data. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.

[5]  J. Lindemans,et al.  Significance of elevated cobalamin (vitamin B12) levels in blood. , 2003, Clinical biochemistry.

[6]  Peter Greaves,et al.  First dose of potential new medicines to humans: how animals help , 2004, Nature Reviews Drug Discovery.

[7]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[8]  Yumiko Sakai,et al.  Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. , 2004, Mutation research.

[9]  D. Lai,et al.  Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance , 2004, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[10]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[11]  Alison Abbott Animal testing: More than a cosmetic change , 2005, Nature.

[12]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[14]  Robert Gentleman,et al.  Statistical Applications in Genetics and Molecular Biology , 2005 .

[15]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[16]  M. Fielden,et al.  The liver pharmacological and xenobiotic gene response repertoire , 2008, Molecular systems biology.

[17]  S. Horslen,et al.  Metabolic liver disease in children , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  Atsushi Ono,et al.  Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. , 2008, Toxicology and applied pharmacology.

[19]  H. Ellinger-Ziegelbauer,et al.  Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. , 2008, Mutation research.

[20]  N. Kiyosawa,et al.  Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy. , 2009, The Journal of toxicological sciences.

[21]  Sven Bergmann,et al.  Modular analysis of gene expression data with R , 2010, Bioinform..

[22]  H Fang,et al.  Genomic indicators in the blood predict drug-induced liver injury , 2010, The Pharmacogenomics Journal.

[23]  H. Yamada,et al.  The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.

[24]  Alexander Amberg,et al.  EU framework 6 project: predictive toxicology (PredTox)--overview and outcome. , 2011, Toxicology and applied pharmacology.

[25]  H. Yamada,et al.  Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database. , 2011, Toxicology and applied pharmacology.

[26]  P. Bushel,et al.  The evolution of bioinformatics in toxicology: advancing toxicogenomics. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  J. Kleinjans,et al.  Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data , 2012, Archives of Toxicology.

[28]  Min Zhang,et al.  A decade of toxicogenomic research and its contribution to toxicological science. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  F. Vernuccio,et al.  Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management. , 2013, World journal of cardiology.

[30]  J. Kleinjans,et al.  Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models. , 2013, Carcinogenesis.

[31]  Katarzyna H. Kaminska,et al.  Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding , 2013, Molecular systems biology.

[32]  T. Uehara,et al.  Toxicogenomics discrimination of potential hepatocarcinogenicity of non‐genotoxic compounds in rat liver , 2012, Journal of applied toxicology : JAT.

[33]  Imir G. Metushi,et al.  Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin , 2014, Molecular and Cellular Biochemistry.

[34]  Joseph J. Babcock,et al.  hERG channel function: beyond long QT , 2013, Acta Pharmacologica Sinica.

[35]  R. Stierum,et al.  Toxicogenomics directory of chemically exposed human hepatocytes , 2014, Archives of Toxicology.

[36]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[37]  Ralf Herwig,et al.  Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. , 2014, Biomarkers in medicine.

[38]  M. Strazzabosco,et al.  Notch signaling and new therapeutic options in liver disease. , 2014, Journal of hepatology.

[39]  Florian Caiment,et al.  Assessing compound carcinogenicity in vitro using connectivity mapping. , 2014, Carcinogenesis.

[40]  J. Zhang,et al.  Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity , 2013, The Pharmacogenomics Journal.

[41]  Henning Hermjakob,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic acids research.

[42]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..